{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:52Z","timestamp":1792782712782,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bando di ricerca finalizzata 2021","award":["GR-2021-12374462"],"award-info":[{"award-number":["GR-2021-12374462"]}]},{"name":"Universit\u00e0 degli Studi di Verona","id":[{"id":"https:\/\/ror.org\/039bp8j42","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Papillary renal neoplasm with reverse polarity (PRNRP) is a recently recognized renal tumor characterized by papillary architecture lined by a single layer of low-grade eosinophilic cells with apically located nuclei. In the latest WHO classification, they are not recognized as a distinct entity but rather as a morphological pattern of papillary renal cell carcinoma. To date, limited studies have compared PRNRP with eosinophilic\/oncocytic papillary renal cell carcinoma (E\/OPRCC), which they are not infrequently confused with, although a few previous comparisons with classic papillary renal cell carcinoma have already identified several distinguishing features. A comparative analysis of 15 of PRNRPs and 16 of E\/OPRCC cases was conducted, evaluating their histopathological, immunophenotypic, interphase cytogenetic, and molecular profiles. PRNRPs demonstrated distinctive morphological features, including consistent apical nuclear positioning, absence of foamy macrophages in the papillary cores (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001), and a lower nucleolar grade compared to E\/OPRCCs (p\u2009= &lt;\u20090.0001). Immunohistochemically, PRNRPs exhibited strong and uniform GATA3 expression and were negative for vimentin, CD10, and CD13, in contrast to E\/OPRCCs. Cytogenetically, PRNRPs lacked trisomies of chromosomes 7 and 17, which were present in\u2009~\u200940% of E\/OPRCCs (p\u2009=\u20090.0262). Notably, all PRNRP cases harbored\n                    <jats:italic>KRAS<\/jats:italic>\n                    mutations, absent in E\/OPRCCs (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Our findings support the classification of PRNRP as a distinct renal tumor entity, separated from both classic papillary renal cell carcinoma and its eosinophilic\/oncocytic morphological variant.\n                  <\/jats:p>","DOI":"10.1007\/s00428-026-04536-9","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:02:16Z","timestamp":1777449736000},"page":"631-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic\/oncocytic papillary renal cell carcinoma"],"prefix":"10.1007","volume":"489","author":[{"given":"Stefano","family":"Marletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cali\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Marcolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Giacometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pedron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Vicentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-7274","authenticated-orcid":false,"given":"Guido","family":"Martignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"4536_CR1","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"H Moch","year":"2016","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th ed. IARC press, Lyon","edition":"4th ed."},{"key":"4536_CR2","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/1097-0142(197612)38:6<2469::aid-cncr2820380636>3.0.co;2-r","volume":"38","author":"R Mancilla-Jimenez","year":"1976","unstructured":"Mancilla-Jimenez R, Stanley RJ, Blath RA (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38:2469\u20132480. https:\/\/doi.org\/10.1002\/1097-0142(197612)38:6%3c2469::aid-cncr2820380636%3e3.0.co;2-r","journal-title":"Cancer"},{"key":"4536_CR3","first-page":"537","volume":"10","author":"B Delahunt","year":"1997","unstructured":"Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537\u2013544","journal-title":"Mod Pathol"},{"key":"4536_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.urology.2006.09.052","volume":"69","author":"G Pignot","year":"2007","unstructured":"Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debr\u00e9 B, Amsellem-Ouazana D (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69:230\u2013235. https:\/\/doi.org\/10.1016\/j.urology.2006.09.052","journal-title":"Urology"},{"key":"4536_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.anndiagpath.2005.12.002","volume":"10","author":"O Hes","year":"2006","unstructured":"Hes O, Brunelli M, Michal M, Cossu Rocca P, Hora M, Chilosi M, Mina M, Boudova L, Menestrina F, Martignoni G (2006) Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 10:133\u2013139. https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.12.002","journal-title":"Ann Diagn Pathol"},{"key":"4536_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00428-003-0787-1","volume":"442","author":"Y Allory","year":"2003","unstructured":"Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A (2003) Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 442:336\u2013342. https:\/\/doi.org\/10.1007\/s00428-003-0787-1","journal-title":"Virchows Arch"},{"key":"4536_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/01.pas.0000184821.09871.ec","volume":"29","author":"M Lef\u00e8vre","year":"2005","unstructured":"Lef\u00e8vre M, Couturier J, Sibony M, Bazille C, Boyer K, Callard P, Vieillefond A, Allory Y (2005) Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 29:1576\u20131581. https:\/\/doi.org\/10.1097\/01.pas.0000184821.09871.ec","journal-title":"Am J Surg Pathol"},{"key":"4536_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"WM Linehan","year":"2016","unstructured":"Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AAM, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MDM, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YSN, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJM, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen Y-B, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R (2016) Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med 374:135\u2013145. https:\/\/doi.org\/10.1056\/NEJMoa1505917","journal-title":"N Engl J Med"},{"key":"4536_CR9","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1097\/PAS.0000000000000962","volume":"41","author":"RM Saleeb","year":"2017","unstructured":"Saleeb RM, Brimo F, Farag M, Rompr\u00e9-Brodeur A, Rotondo F, Beharry V, Wala S, Plant P, Downes MR, Pace K, Evans A, Bjarnason G, Bartlett JMS, Yousef GM (2017) Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis. Am J Surg Pathol 41:1618\u20131629. https:\/\/doi.org\/10.1097\/PAS.0000000000000962","journal-title":"Am J Surg Pathol"},{"key":"4536_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1440-1827.2009.02341.x","volume":"59","author":"B-H Park","year":"2009","unstructured":"Park B-H, Ro JY, Park WS, Jee KJ, Kim K, Gong G, Cho YM (2009) Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course. Pathol Int 59:137\u2013146. https:\/\/doi.org\/10.1111\/j.1440-1827.2009.02341.x","journal-title":"Pathol Int"},{"key":"4536_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","volume":"43","author":"KI Al-Obaidy","year":"2019","unstructured":"Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ (2019) Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol 43:1099\u20131111. https:\/\/doi.org\/10.1097\/PAS.0000000000001288","journal-title":"Am J Surg Pathol"},{"key":"4536_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/PAS.0000000000001189","volume":"43","author":"A Cali\u00f2","year":"2019","unstructured":"Cali\u00f2 A, Warfel KA, Eble JN (2019) Papillary adenomas and other small epithelial tumors in the kidney: an autopsy study. Am J Surg Pathol 43:277\u2013287. https:\/\/doi.org\/10.1097\/PAS.0000000000001189","journal-title":"Am J Surg Pathol"},{"key":"4536_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","volume":"33","author":"KI Al-Obaidy","year":"2020","unstructured":"Al-Obaidy KI, Eble JN, Nassiri M, Cheng L, Eldomery MK, Williamson SR, Sakr WA, Gupta N, Hassan O, Idrees MT, Grignon DJ (2020) Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Mod Pathol 33:1157\u20131164. https:\/\/doi.org\/10.1038\/s41379-019-0362-1","journal-title":"Mod Pathol"},{"key":"4536_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/PAS.0000000000002442","volume":"49","author":"JW Kwon","year":"2025","unstructured":"Kwon JW, Wang P, Wanjari P, Wuori D, Paik J, Pytel P, Fitzpatrick C, Tjota MY, Antic T (2025) Renal tumorigenesis via RAS\/RAF\/MAPK pathway alterations beyond papillary renal neoplasm with reverse polarity. Am J Surg Pathol 49:1266\u20131278. https:\/\/doi.org\/10.1097\/PAS.0000000000002442","journal-title":"Am J Surg Pathol"},{"key":"4536_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41379-019-0420-8","volume":"33","author":"SS Kim","year":"2020","unstructured":"Kim SS, Cho YM, Kim GH, Kee KH, Kim H-S, Kim KM, Kim J-H, Choi C (2020) Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma. Mod Pathol 33:690\u2013699. https:\/\/doi.org\/10.1038\/s41379-019-0420-8","journal-title":"Mod Pathol"},{"key":"4536_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/his.14084","volume":"76","author":"K Tong","year":"2020","unstructured":"Tong K, Zhu W, Fu H, Cao F, Wang S, Zhou W, Liu C, Chen D, Fan S, Hu Z (2020) Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Histopathology 76:1070\u20131083. https:\/\/doi.org\/10.1111\/his.14084","journal-title":"Histopathology"},{"key":"4536_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/1066896920918289","volume":"28","author":"L Zhou","year":"2020","unstructured":"Zhou L, Xu J, Wang S, Yang X, Li C, Zhou J, Zhang P, Xu H, Wang C (2020) Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 7 cases. Int J Surg Pathol 28:728\u2013734. https:\/\/doi.org\/10.1177\/1066896920918289","journal-title":"Int J Surg Pathol"},{"key":"4536_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.humpath.2022.06.016","volume":"127","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang H, Li X, Wang S, Zhang Y, Zhang X, Xu T, Dong Y, Dong L, Zhou L, Yang X, Wang C (2022) Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma. Hum Pathol 127:78\u201385. https:\/\/doi.org\/10.1016\/j.humpath.2022.06.016","journal-title":"Hum Pathol"},{"key":"4536_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/pin.13417","volume":"74","author":"VF Castillo","year":"2024","unstructured":"Castillo VF, Trpkov K, Van der Kwast T, Rotondo F, Hamdani M, Saleeb R (2024) Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma. Pathol Int 74:222\u2013226. https:\/\/doi.org\/10.1111\/pin.13417","journal-title":"Pathol Int"},{"key":"4536_CR20","unstructured":"(2022) WHO Classification of Tumours Editorial Board, ed., WHO classification of tumours, urinary and male genital tumours, 5th ed., IARC press, Lyon"},{"key":"4536_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prp.2016.04.009","volume":"213","author":"G Han","year":"2017","unstructured":"Han G, Yu W, Chu J, Liu Y, Jiang Y, Li Y, Zhang W (2017) Oncocytic papillary renal cell carcinoma: a clinicopathological and genetic analysis and indolent clinical course in 14 cases. Pathol Res Pract 213:1\u20136. https:\/\/doi.org\/10.1016\/j.prp.2016.04.009","journal-title":"Pathol Res Pract"},{"key":"4536_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.MP.0000090923.50509.55","volume":"16","author":"M Brunelli","year":"2003","unstructured":"Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L (2003) Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 16:1060\u20131063. https:\/\/doi.org\/10.1097\/01.MP.0000090923.50509.55","journal-title":"Mod Pathol"},{"key":"4536_CR23","volume-title":"AJCC Cancer Staging Manual","author":"Amenican Joint Committee on Cancer","year":"2017","unstructured":"Amenican Joint Committee on Cancer (2017) AJCC Cancer Staging Manual, 8th ed. Springer US, Chicago, USA","edition":"8th ed."},{"key":"4536_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anndiagpath.2018.01.010","volume":"35","author":"K Michalova","year":"2018","unstructured":"Michalova K, Steiner P, Alaghehbandan R, Trpkov K, Martinek P, Grossmann P, Montiel DP, Sperga M, Straka L, Prochazkova K, Cempirkova D, Horava V, Bulimbasic S, Pivovarcikova K, Daum O, Ondic O, Rotterova P, Michal M, Hora M, Hes O (2018) Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: analysis of 10 cases. Ann Diagn Pathol 35:1\u20136. https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.01.010","journal-title":"Ann Diagn Pathol"},{"key":"4536_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1541692","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Guan L, Liu Y, Liu Y, Guo X, Sun Y (2024) Oncocytic papillary renal cell carcinoma (OPRCC): 2 case report and literature review. Front Oncol 14:1541692. https:\/\/doi.org\/10.3389\/fonc.2024.1541692","journal-title":"Front Oncol"},{"key":"4536_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/tau-23-518","volume":"13","author":"H Han","year":"2024","unstructured":"Han H, Yin S-Y, Song R-X, Zhao J, Yu Y-W, He M-X, Wang H (2024) Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation. Transl Androl Urol 13:383\u2013396. https:\/\/doi.org\/10.21037\/tau-23-518","journal-title":"Transl Androl Urol"},{"key":"4536_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2025.152498","volume":"80","author":"YI Lee","year":"2026","unstructured":"Lee YI, Park J-M, Yoon SY, Song C, Cho YM (2026) Papillary renal neoplasm with reverse polarity shows benign behavior: results from a 77-case clinicopathological and molecular study. Ann Diagn Pathol 80:152498. https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152498","journal-title":"Ann Diagn Pathol"},{"key":"4536_CR28","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1093\/ndt\/gfs457","volume":"27","author":"E Olinger","year":"2012","unstructured":"Olinger E, Schwaller B, Loffing J, Gailly P, Devuyst O (2012) Parvalbumin: calcium and magnesium buffering in the distal nephron. Nephrol Dial Transplant 27:3988\u20133994. https:\/\/doi.org\/10.1093\/ndt\/gfs457","journal-title":"Nephrol Dial Transplant"},{"key":"4536_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/modpathol.3880386","volume":"14","author":"G Martignoni","year":"2001","unstructured":"Martignoni G, Pea M, Chilosi M, Brunelli M, Scarpa A, Colato C, Tardanico R, Zamboni G, Bonetti F (2001) Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 14:760\u2013767. https:\/\/doi.org\/10.1038\/modpathol.3880386","journal-title":"Mod Pathol"},{"key":"4536_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1309\/AJCPSATJTKBI6J4N","volume":"133","author":"M Brunelli","year":"2010","unstructured":"Brunelli M, Delahunt B, Gobbo S, Tardanico R, Eccher A, Bersani S, Cossu-Rocca P, Parolini C, Balzarini P, Menestrina F, Cheng L, Eble JN, Martignoni G (2010) Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Am J Clin Pathol 133:116\u2013126. https:\/\/doi.org\/10.1309\/AJCPSATJTKBI6J4N","journal-title":"Am J Clin Pathol"},{"key":"4536_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/modpathol.3800236","volume":"17","author":"G Martignoni","year":"2004","unstructured":"Martignoni G, Pea M, Brunelli M, Chilosi M, Zam\u00f3 A, Bertaso M, Cossu-Rocca P, Eble JN, Mikuz G, Puppa G, Badoual C, Ficarra V, Novella G, Bonetti F (2004) CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 17:1455\u20131463. https:\/\/doi.org\/10.1038\/modpathol.3800236","journal-title":"Mod Pathol"},{"key":"4536_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cll.2005.01.004","volume":"25","author":"M Zhou","year":"2005","unstructured":"Zhou M, Roma A, Magi-Galluzzi C (2005) The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 25:247\u2013257. https:\/\/doi.org\/10.1016\/j.cll.2005.01.004","journal-title":"Clin Lab Med"},{"key":"4536_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","volume":"30","author":"SK Tickoo","year":"2006","unstructured":"Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141\u2013153. https:\/\/doi.org\/10.1097\/01.pas.0000185382.80844.b1","journal-title":"Am J Surg Pathol"},{"key":"4536_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pathol.2016.05.014","volume":"49","author":"G Martignoni","year":"2017","unstructured":"Martignoni G, Brunelli M, Segala D, Munari E, Gobbo S, Cima L, Borze I, Wirtanen T, Sarhadi VK, Atanesyan L, Savola S, Barzon L, Masi G, Fassan M, Eble JN, Bohling T, Cheng L, Delahunt B, Knuutila S (2017) Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker. Pathology 49:10\u201318. https:\/\/doi.org\/10.1016\/j.pathol.2016.05.014","journal-title":"Pathology"},{"key":"4536_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","volume":"138","author":"H Liu","year":"2012","unstructured":"Liu H, Shi J, Wilkerson ML, Lin F (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138:57\u201364. https:\/\/doi.org\/10.1309\/AJCP5UAFMSA9ZQBZ","journal-title":"Am J Clin Pathol"},{"key":"4536_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.humpath.2017.06.016","volume":"66","author":"JG Mantilla","year":"2017","unstructured":"Mantilla JG, Antic T, Tretiakova M (2017) GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Hum Pathol 66:152\u2013158. https:\/\/doi.org\/10.1016\/j.humpath.2017.06.016","journal-title":"Hum Pathol"},{"key":"4536_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.urolonc.2024.12.187","volume":"43","author":"AL Sanmiguel","year":"2025","unstructured":"Sanmiguel AL, Hakimi AA, Khandwala Y, Calderon LP, Dawidek M, Chen Y-B, Russo P, Coleman J, Carlo M (2025) Clinical and genomic characterization of a single-center cohort of renal cell carcinoma patients with KRAS mutation. Urol Oncol Semin Orig Investig 43:74. https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.187","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"4536_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAI.0000000000000435","volume":"26","author":"M Brunelli","year":"2018","unstructured":"Brunelli M, Erdini F, Cima L, Eccher A, Fioravanzo A, Gobbo S, Segala D, Ghimenton C, Mazzoleni G, Munari E, Carella R, Martignoni G (2018) Proximal CD13 versus distal GATA-3 expression in renal neoplasia according to WHO 2016 classification. Appl Immunohistochem Mol Morphol 26:316\u2013323. https:\/\/doi.org\/10.1097\/PAI.0000000000000435","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"4536_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.anndiagpath.2017.11.004","volume":"40","author":"T Pitra","year":"2019","unstructured":"Pitra T, Pivovarcikova K, Alaghehbandan R, Hes O (2019) Chromosomal numerical aberration pattern in papillary renal cell carcinoma: review article. Ann Diagn Pathol 40:189\u2013199. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.11.004","journal-title":"Ann Diagn Pathol"},{"key":"4536_CR40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/PAS.0000000000001773","volume":"46","author":"S Wei","year":"2022","unstructured":"Wei S, Kutikov A, Patchefsky AS, Flieder DB, Talarchek JN, Al-Saleem T, Dulaimi E, Uzzo RG, Testa JR, Pei J (2022) Papillary renal neoplasm with reverse polarity is often cystic: report of 7 cases and review of 93 cases in the literature. Am J Surg Pathol 46:336\u2013343. https:\/\/doi.org\/10.1097\/PAS.0000000000001773","journal-title":"Am J Surg Pathol"},{"key":"4536_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00428-024-03840-6","volume":"485","author":"D Kiyozawa","year":"2024","unstructured":"Kiyozawa D, Iwasaki T, Takamatsu D, Kohashi K, Miyamoto T, Fukuchi G, Eto M, Yamashita M, Oda Y (2024) Papillary renal neoplasm with reverse polarity has low frequency of alterations in chromosomes 7, 17, and Y. Virchows Arch 485:299\u2013306. https:\/\/doi.org\/10.1007\/s00428-024-03840-6","journal-title":"Virchows Arch"},{"key":"4536_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.930296","volume":"12","author":"M Shen","year":"2022","unstructured":"Shen M, Yin X, Bai Y, Zhang H, Ru G, He X, Teng X, Chen G, Zhao M (2022) Papillary renal neoplasm with reverse polarity: a clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity. Front Oncol 12:930296. https:\/\/doi.org\/10.3389\/fonc.2022.930296","journal-title":"Front Oncol"},{"key":"4536_CR43","doi-asserted-by":"publisher","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, Antonini P, Martelli FM, Marcolini L, Stefanizzi L, Martignoni G (2024) TFE3-rearranged tumors of the kidney: an emerging conundrum. Cancers (Basel) 16. https:\/\/doi.org\/10.3390\/cancers16193396","DOI":"10.3390\/cancers16193396"},{"key":"4536_CR44","first-page":"3137","volume":"31","author":"M Brunelli","year":"2011","unstructured":"Brunelli M, Segala D, Delahunt B, Parolini C, Bersani S, Cheng L, Eble JN, Chilosi M, Gobbo S, Martignoni G (2011) FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma. Anticancer Res 31:3137\u20133142","journal-title":"Anticancer Res"},{"key":"4536_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","volume":"17","author":"L Buscail","year":"2020","unstructured":"Buscail L, Bournet B, Cordelier P (2020) Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol 17:153\u2013168. https:\/\/doi.org\/10.1038\/s41575-019-0245-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4536_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cllc.2012.09.007","volume":"14","author":"N Karachaliou","year":"2013","unstructured":"Karachaliou N, Mayo C, Costa C, Magr\u00ed I, Gimenez-Capitan A, Molina-Vila MA, Rosell R (2013) KRAS mutations in lung cancer. Clin Lung Cancer 14:205\u2013214. https:\/\/doi.org\/10.1016\/j.cllc.2012.09.007","journal-title":"Clin Lung Cancer"},{"key":"4536_CR47","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.3390\/ijms131012153","volume":"13","author":"AK Arrington","year":"2012","unstructured":"Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci 13:12153\u201312168. https:\/\/doi.org\/10.3390\/ijms131012153","journal-title":"Int J Mol Sci"},{"key":"4536_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.32074\/1591-951X-814","volume":"115","author":"A Cali\u00f2","year":"2022","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, Martignoni G (2022) WHO 2022 classification of kidney tumors: what is relevant? An update and future novelties for the pathologist. Pathologica 115:23\u201331. https:\/\/doi.org\/10.32074\/1591-951X-814","journal-title":"Pathologica"},{"key":"4536_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2025.152530","volume":"80","author":"SR Williamson","year":"2026","unstructured":"Williamson SR, Al-Obaidy KI (2026) Papillary renal neoplasm with reverse polarity: a distinct entity ready for the World Health Organization classification. Ann Diagn Pathol 80:152530. https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152530","journal-title":"Ann Diagn Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04536-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:23:33Z","timestamp":1789550613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04536-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4536"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04536-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants received institutional review board approval (Prog. 4136CESC) and were in accordance with the ethical standards of the institutional and\/or national research committee and with the declaration of Helsinki.","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}